- Home
- ACRV vs MPU Comparison
ACRV vs MPU Comparison
Compare ACRV & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- MPU
- Stock Information
- Founded
- ACRV 2018
- MPU 1989
- Country
- ACRV United States
- MPU Singapore
- Employees
- ACRV N/A
- MPU N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- MPU Transportation Services
- Sector
- ACRV Health Care
- MPU Consumer Discretionary
- Exchange
- ACRV Nasdaq
- MPU Nasdaq
- Market Cap
- ACRV 36.1M
- MPU 40.0M
- IPO Year
- ACRV 2022
- MPU 1998
- Fundamental
- Price
- ACRV $1.09
- MPU $0.91
- Analyst Decision
- ACRV Buy
- MPU
- Analyst Count
- ACRV 7
- MPU 0
- Target Price
- ACRV $17.60
- MPU N/A
- AVG Volume (30 Days)
- ACRV 728.6K
- MPU 226.0K
- Earning Date
- ACRV 05-14-2025
- MPU 06-10-2025
- Dividend Yield
- ACRV N/A
- MPU N/A
- EPS Growth
- ACRV N/A
- MPU N/A
- EPS
- ACRV N/A
- MPU N/A
- Revenue
- ACRV N/A
- MPU $36,184,000.00
- Revenue This Year
- ACRV N/A
- MPU N/A
- Revenue Next Year
- ACRV N/A
- MPU N/A
- P/E Ratio
- ACRV N/A
- MPU N/A
- Revenue Growth
- ACRV N/A
- MPU N/A
- 52 Week Low
- ACRV $1.05
- MPU $0.49
- 52 Week High
- ACRV $10.16
- MPU $1.98
- Technical
- Relative Strength Index (RSI)
- ACRV 34.87
- MPU 51.89
- Support Level
- ACRV $1.06
- MPU $0.78
- Resistance Level
- ACRV $1.19
- MPU $1.05
- Average True Range (ATR)
- ACRV 0.09
- MPU 0.09
- MACD
- ACRV 0.05
- MPU -0.00
- Stochastic Oscillator
- ACRV 21.57
- MPU 50.26
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.